| Item Type | Name |
|
Academic Article
|
Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial.
|
|
Concept
|
Intensive Care Units
|
|
Concept
|
World Health Organization
|
|
Concept
|
Global Health
|
|
Academic Article
|
Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
|
|
Academic Article
|
Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia.
|
|
Academic Article
|
Report of an international working group to standardize response criteria for myelodysplastic syndromes.
|
|
Academic Article
|
Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma.
|
|
Academic Article
|
Insurance policies in the United States may explain part of the outcome differences of adolescents and young adults with acute lymphoblastic leukemia treated on adult versus pediatric regimens.
|
|
Academic Article
|
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal.
|
|
Academic Article
|
Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions.
|
|
Academic Article
|
Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
|
|
Academic Article
|
An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.
|
|
Academic Article
|
Impact of cancer research bureaucracy on innovation, costs, and patient care.
|
|
Academic Article
|
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
|
|
Academic Article
|
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.
|
|
Academic Article
|
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.
|
|
Academic Article
|
Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia.
|
|
Academic Article
|
Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia.
|
|
Academic Article
|
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).
|
|
Academic Article
|
Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia
|
|
Academic Article
|
Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034.
|
|
Academic Article
|
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
|
|
Academic Article
|
Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-M?nster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
|
|
Academic Article
|
Time-dependent changes in mortality and transformation risk in MDS.
|
|
Academic Article
|
Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.
|
|
Academic Article
|
Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies.
|
|
Academic Article
|
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial.
|
|
Academic Article
|
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
|
|
Academic Article
|
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study.
|
|
Academic Article
|
Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories.
|
|
Academic Article
|
The opioid epidemic in the United States-Overview, origins, and potential solutions.
|
|
Concept
|
Patient Safety
|
|
Academic Article
|
Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia.
|
|
Academic Article
|
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1.
|
|
Academic Article
|
Strategies that delay or prevent the timely availability of affordable generic drugs in the United States.
|
|
Academic Article
|
The Hyper-CVAD Regimen is an Optimal Pediatric-inspired Regimen for Adolescents and Adults With Acute Lymphoblastic Leukemia.
|
|
Academic Article
|
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic?Neoplasms.
|